trifluoperazine 1mg tablets
creo pharma ltd - trifluoperazine hydrochloride - oral tablet - 1mg
trifluoperazine 1mg tablets
ennogen pharma ltd - trifluoperazine hydrochloride - oral tablet - 1mg
trifluoperazine 5mg/5ml oral solution sugar free
rosemont pharmaceuticals ltd - trifluoperazine hydrochloride - oral solution - 1mg/1ml
trifluoperazine 5mg tablets
consilient health ltd - trifluoperazine hydrochloride - oral tablet - 5mg
trifluoperazine 5mg tablets
phoenix healthcare distribution ltd - trifluoperazine hydrochloride - oral tablet - 5mg
trifluoperazine 5mg tablets
special order - trifluoperazine hydrochloride - oral tablet - 5mg
trifluoperazine hydrochloride tablet, film coated
remedyrepack inc. - trifluoperazine hydrochloride (unii: 6p1y2snf5v) (trifluoperazine - unii:214izi85k3) - for the management of schizophrenia. trifluoperazine hydrochloride tablets, usp are effective for the short-term treatment of generalized non-psychotic anxiety. however, trifluoperazine hydrochloride tablets are not the first drug to be used in therapy for most patients with non-psychotic anxiety because certain risks associated with its use are not shared by common alternative treatments (i.e., benzodiazepines). when used in the treatment of non-psychotic anxiety, trifluoperazine hydrochloride tablets should not be administered at doses of more than 6 mg per day or for longer than 12 weeks because the use of trifluoperazine hydrochloride tablets at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible (see warnings). the effectiveness of trifluoperazine hydrochloride tablets as a treatment for non-psychotic anxiety was established in a 4-week clinical multicenter study of outpatients with generalized anxiety disorder (dsm-iii). this evidence does not predict that trifluoperazine hydrochloride tablets will be useful in patients with other non-psychotic conditions in which anxiety, or signs that mimic anxiety, are found (i.e., physical illness, organic mental conditions, agitated depression, character pathologies, etc.). trifluoperazine hydrochloride tablets have not been shown effective in the management of behavioral complications in patients with mental retardation. a known hypersensitivity to phenothiazines, comatose or greatly depressed states due to central nervous system depressants and, in cases of existing blood dyscrasias, bone marrow depression and preexisting liver damage.
stelazine 1mg tablets/trifluoperazine 1mg tablets
mercury pharmaceuticals limited capital house, 85 king william street, london ec4n 7bl, united kingdom - trifluoperazine hydrochloride - tablet - trifluoperazine hydrochloride 1 mg - psycholeptics
stelazine 5mg tablets/trifluoperazine 5mg tablets
mercury pharmaceuticals limited capital house, 85 king william street, london ec4n 7bl, united kingdom - trifluoperazine hydrochloride - tablet - trifluoperazine hydrochloride 5 mg - psycholeptics
trifluoperazine 5mg tablets
a a h pharmaceuticals ltd - trifluoperazine hydrochloride - oral tablet - 5mg